Article
Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study.
Frontiers in immunology - 1 Jan 2022
Vandebergh Marijne, Becelaere Sara, Dubois Bénédicte, Goris An
Abstract excerpt
Objectives: We explored whether genetically predicted increased body mass index (BMI) modulates multiple sclerosis (MS) risk through interleukin-6 (IL-6) signaling. Methods: We performed a two-sample Mendelian randomization (MR) study using multiple genome-wide association studies (GWAS) datasets for BMI, IL-6 signaling, IL-6 levels and c-reactive protein (CRP) levels as exposures and estimated their effects on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
